Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FBNQZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency on September 19, 2025, for Stelara 90 mg/ml syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 10, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which enables the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting military health facility supply needs.
The Defense Logistics Agency utilizes the SPE2DB program to procure pharmaceutical products, including branded and generic prescription drugs, biologics, and specialty medications for Department of Defense healthcare facilities nationwide. Stelara, an immunosuppressant biologic medication, represents one of the specialized pharmaceutical products within DMS Pharmaceutical Group's extensive federal contract portfolio. The company's established presence as a critical pharmaceutical supplier in the federal supply chain, combined with its consistent track record of fulfilling delivery orders for medical products ranging from injectable biologics to oncology treatments, positions it as a reliable vendor for military healthcare logistics.
Quick answers
Who was awarded contract SPE2DB25FBNQZ?
SPE2DB25FBNQZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FBNQZ worth?
The government has obligated $16,250 on SPE2DB25FBNQZ.
Is contract SPE2DB25FBNQZ an order under another contract?
Yes. SPE2DB25FBNQZ is a delivery order under SPE2DB24D9211, an indefinite delivery contract.
Was contract SPE2DB25FBNQZ competed?
The extent of competition for SPE2DB25FBNQZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award